The Digital Press

A former Google employee reflects on the company's early efforts in applying AI to biology and praises DeepMind's recent advances in the field, while noting some important challenges remain unaddressed.

Why it matters: DeepMind is pushing AI-driven biological research forward, potentially accelerating breakthroughs in drug discovery and genomics.

The big picture: Distinguishing causal genetic variants remains a key challenge for effective drug targeting, not yet solved by current AI models.

The other side: Some see DeepMind’s work as partly a marketing tool tied to launching new services like AlphaGenome for non-commercial use.

Commenters say: Readers admire DeepMind’s progress and technical prowess but want more focus on biological causality and realistic cellular simulations.